| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |